LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | PI103 | 10.0 | uM | LJP6 | 72 | hr | 658 | 909 | 3846 | 0.2364 | 0.0788 |
Hs 578T | PLX-4720 | 10.0 | uM | LJP5 | 72 | hr | 658 | 2868 | 3846 | 0.7457 | 0.6932 |
Hs 578T | QL-X-138 | 10.0 | uM | LJP6 | 72 | hr | 658 | 573 | 3846 | 0.1490 | -0.0267 |
Hs 578T | QL-XII-47 | 10.0 | uM | LJP6 | 72 | hr | 658 | 578 | 3846 | 0.1503 | -0.0252 |
Hs 578T | Radicicol | 10.0 | uM | LJP5 | 72 | hr | 658 | 643 | 3846 | 0.1672 | -0.0048 |
Hs 578T | Radicicol | 10.0 | uM | LJP6 | 72 | hr | 658 | 609 | 3846 | 0.1585 | -0.0152 |
Hs 578T | Seliciclib | 10.0 | uM | LJP5 | 72 | hr | 658 | 2298 | 3846 | 0.5977 | 0.5146 |
Hs 578T | Ruxolitinib | 10.0 | uM | LJP5 | 72 | hr | 658 | 2661 | 3846 | 0.6920 | 0.6285 |
Hs 578T | XL147 | 10.0 | uM | LJP5 | 72 | hr | 658 | 3179 | 3846 | 0.8266 | 0.7907 |
Hs 578T | Saracatinib | 10.0 | uM | LJP6 | 72 | hr | 658 | 1574 | 3846 | 0.4094 | 0.2875 |
Hs 578T | Selumetinib | 10.0 | uM | LJP6 | 72 | hr | 658 | 1216 | 3846 | 0.3163 | 0.1751 |
Hs 578T | Sirolimus | 10.0 | uM | LJP6 | 72 | hr | 658 | 2466 | 3846 | 0.6412 | 0.5671 |
Hs 578T | Sorafenib | 10.0 | uM | LJP6 | 72 | hr | 658 | 2751 | 3846 | 0.7154 | 0.6567 |
Hs 578T | SU11274 | 10.0 | uM | LJP5 | 72 | hr | 658 | 966 | 3846 | 0.2513 | 0.0968 |
Hs 578T | Fedratinib | 10.0 | uM | LJP5 | 72 | hr | 658 | 373 | 3846 | 0.0971 | -0.0894 |
Hs 578T | TGX221 | 10.0 | uM | LJP5 | 72 | hr | 658 | 2967 | 3846 | 0.7714 | 0.7242 |
Hs 578T | Torin1 | 10.0 | uM | LJP6 | 72 | hr | 658 | 459 | 3846 | 0.1195 | -0.0623 |
Hs 578T | Torin2 | 10.0 | uM | LJP5 | 72 | hr | 658 | 447 | 3846 | 0.1164 | -0.0660 |
Hs 578T | Tozasertib | 10.0 | uM | LJP5 | 72 | hr | 658 | 786 | 3846 | 0.2044 | 0.0401 |
Hs 578T | Trametinib | 10.0 | uM | LJP5 | 72 | hr | 658 | 946 | 3846 | 0.2461 | 0.0904 |
Hs 578T | TWS119 | 10.0 | uM | LJP5 | 72 | hr | 658 | 606 | 3846 | 0.1576 | -0.0164 |
Hs 578T | Vemurafenib | 10.0 | uM | LJP5 | 72 | hr | 658 | 1915 | 3846 | 0.4981 | 0.3945 |
Hs 578T | Withaferin A | 10.0 | uM | LJP5 | 72 | hr | 658 | 397 | 3846 | 0.1032 | -0.0819 |
Hs 578T | Withaferin A | 10.0 | uM | LJP6 | 72 | hr | 658 | 338 | 3846 | 0.0881 | -0.1002 |
Hs 578T | WYE-125132 | 10.0 | uM | LJP6 | 72 | hr | 658 | 1014 | 3846 | 0.2637 | 0.1117 |